Search - tctmd.com

Displaying 501 - 520 of 1325

Sort: Relevancy | Date

News Conference News ACC 2018

Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease

Yael L. Maxwell

March 09, 2018

News Daily News

‘Weekend Effect’ Still a Reality for ACS Patients in Italy

Caitlin E. Cox

March 06, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Conference News ACC 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Michael O'Riordan

March 01, 2018

News Daily News

Early Invasive Strategy Linked to Worse QoL in Elderly NSTEMI Patients

L.A. McKeown

January 23, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Women Have Higher Risk of Unplanned Readmission After PCI

Michael O'Riordan

January 12, 2018

News Daily News

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

Todd Neale

December 15, 2017

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

News Daily News

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

Todd Neale

December 01, 2017

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Daily News

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

L.A. McKeown

November 21, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

Advertisement

Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease

‘Weekend Effect’ Still a Reality for ACS Patients in Italy

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Early Invasive Strategy Linked to Worse QoL in Elderly NSTEMI Patients

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Women Have Higher Risk of Unplanned Readmission After PCI

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Radial Access Best for PCI Following Thrombolysis in STEMI

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content